中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
Author:( Toyohi ISSE)

1.Lung Cancer and \it{CYP1A1} or \it{GSTM1} Polymorphisms

Tsunehiro OYAMA ; Norio KAGAWA ; Yong-Dae KIM ; Akiko MATSUMOTO ; Toyohi ISSE ; Toshihiro KAWAMOTO

Environmental Health and Preventive Medicine 2002;7(6):230-234

2.Lung cancer andCYP1A1 orGSTM1 polymorphisms.

Tsunehiro OYAMA ; Norio KAGAWA ; Yong-Dae KIM ; Akiko MATSUMOTO ; Toyohi ISSE ; Toshihiro KAWAMOTO

Environmental Health and Preventive Medicine 2003;7(6):230-234

3.International comparison of criteria for evaluating sensitization of PRTR-designated chemical substances.

Tomoe MURAKAMI ; Tsunehiro OYAMA ; Toyohi ISSE ; Masanori OGAWA ; Takuya SUGIE ; Toshihiro KAWAMOTO

Environmental Health and Preventive Medicine 2007;12(2):56-65

4.Evidence-based prevention (EBP): A review of cytochrome P450 expression in the bronchial epithelium and new approach to lung cancer prevention.

Tsunehiro OYAMA ; Toyohi ISSE ; Tomoe MURAKAMI ; Rie SUZUKI-NARAI ; Masanori OGAWA ; Tetsunosuke YAMAGUCHI ; Tsuyoshi KINAGA ; Yasunori YASHIMA ; Shinichi OZAKI ; Yong-Dae KIM ; Heon KIM ; Toshihiro KAWAMOTO

Environmental Health and Preventive Medicine 2006;11(3):97-101

5.Evaluation of chemical-specific IgG antibodies in male workers from a urethane foam factory.

Mayumi TSUJI ; Yasuhiro ISHIHARA ; Toyohi ISSE ; Chihaya KORIYAMA ; Megumi YAMAMOTO ; Noriaki KAKIUCHI ; Hsu-Sheng YU ; Masayuki TANAKA ; Takuto TSUCHIYA ; Masanori OHTA ; Rie TANAKA ; Toshihiro KAWAMOTO

Environmental Health and Preventive Medicine 2018;23(1):24-24

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO